Sustainability | May 20, 2022
Pharma companies with ESG more valuable say investors
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Pharmapack Europe recognizes excellence and innovation from exhibitors across connected devices, sustainability, supply chain logistics, route of administration, and packaging innovation, as well from the wider industry for patient-centric design and eco-design
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills
The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology
Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter
The pharma companies will bring quality products at competitive prices to consumers in Oman and help bring down the cost of healthcare
India has the second-largest number of adults with diabetes globally, after China
ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment
Subscribe To Our Newsletter & Stay Updated
